Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
Titel:
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
Auteur:
Richeldi, Luca Fernández Pérez, Evans R Costabel, Ulrich Albera, Carlo Lederer, David J Flaherty, Kevin R Ettinger, Neil Perez, Rafael Scholand, Mary Beth Goldin, Jonathan Peony Yu, Kin-Hung Neff, Thomas Porter, Seth Zhong, Ming Gorina, Eduard Kouchakji, Elias Raghu, Ganesh